Global Information
회사소개 | 문의 | 비교리스트

세계의 이분척추증 치료 시장(2019-2025년)

Spina Bifida Treatment Market 2019-2025

리서치사 Orion Market Research Pvt Ltd
발행일 2020년 06월 상품 코드 949549
페이지 정보 영문
가격
US $ 3,600 ₩ 4,252,000 Unprintable PDF (Single User License)
US $ 4,800 ₩ 5,670,000 Printable PDF (Enterprise License)


세계의 이분척추증 치료 시장(2019-2025년) Spina Bifida Treatment Market 2019-2025
발행일 : 2020년 06월 페이지 정보 : 영문

유아 질환의 증가와 의료의 진보가 세계 이분척추증 치료 시장의 성장을 촉진하고 있습니다. 또한 인식의 향상, 정부 지원의 증가, 자금조달과 상환의 증가에 의해 이 시장의 성장이 촉진되고 있습니다.

세계의 이분척추증 치료 시장은 유형과 치료법에 기반하여 분할되고 있습니다. 유형별로 시장은 잠재성, 폐쇄 신경관 결손, 수막류 및 척수수막류으로 분할됩니다. 그리고 치료법별로 시장은 수술, 의료 시술 및 디바이스로 분할됩니다. 수술에 기반하는 분류에서 시장은 한층 더 제왕절개, 치골상 방광루조설술, 척추 수술, 인공 항문 등으로 분할됩니다. 의료 시술에 기반하는 분류에서 시장은 요로 카테터법, 요로 변경, 관장으로 분할되고 있습니다.

지역적으로 시장은 북미, 유럽, 아시아태평양 및 기타 지역(RoW)을 포함한 4개의 주요 지역으로 분류됩니다. 북미는 세계의 이분척추증 치료 시장에서 큰 시장 점유율을 차지할 것으로 예상되고 있습니다. 아시아태평양은 많은 환자 수와 건강에 대한 인식의 향상에 의해 가장 급성장하고 있는 이분척추증 치료 시장입니다. 또한 정부가 지원하는 계몽 활동, 정부 지원의 증가, 자금조달과 상환의 증가에 의해 시장의 성장이 촉진되고 있습니다.

Medtronic PLC, Boston Scientific Corp., Karl Storz SE&Co. KG, Johnson&Johnson Service Inc., Zimmer Biomet Holdings Inc., NuVasive Inc., Smith&Nephew PLC, Stryker Corp 및 Wellspect Healthcare(A Dentsply Sirona Company) 등이 이분척추증 치료를 제공하는 주요 기업입니다. 시장 기업이 세계 규모에서의 경쟁력을 높이기 위해 채택하는 전략에는 합병사업 및 제품 발매가 포함됩니다.

세계의 이분척추증 치료 시장을 조사했으며, 시장의 개요, 시장 성장요인 및 저해요인 분석, 유형·치료법·지역별 시장 규모의 추이와 예측, 경쟁 구도, 주요 기업의 개요, 시장 기회 등의 정보를 정리하여 전해드립니다.

목차

제1장 리포트의 개요

제2장 시장 개요와 인사이트

  • 조사 범위
  • 애널리스트의 인사이트와 현재의 시장 동향

제3장 경쟁 구도

  • 회사 점유율 분석
  • 주요 전략 분석
  • 주요 기업 분석
    • Medtronic PLC
    • Boston Scientific Corp.
    • Karl Storz SE&Co. KG
    • Johnson&Johnson Service, Inc.
    • Zimmer Biomet Holdings, Inc.

제4장 시장 결정요인

  • 동기
  • 억제요인
  • 시장 기회

제5장 시장 세분화

  • 유형별
    • 잠재성
    • 폐쇄 신경관 결손
    • 수막류
    • 척수수막류
  • 치료법별
    • 수술
    • 의료 시술
    • 디바이스

제6장 지역 분석

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 이탈리아
    • 스페인
    • 프랑스
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 기타 아시아태평양
  • 기타 지역

제7장 기업 개요

  • B. Braun Melsungen AG
  • Boston Scientific Corp.
  • C.R. Bard, Inc.(Becton, Dickinson and Co.)
  • Coloplast A/S
  • ConvaTec Group PLC
  • Cook Medical, Inc.
  • Johnson & Johnson Service, Inc.
  • Karl Storz SE & Co. KG
  • Medtronic PLC
  • NuVasive, Inc.
  • Smith & Nephew PLC
  • Stryker Corp.
  • Teleflex, Inc.
  • Wellspect Healthcare(A Dentsply Sirona Company)
  • Zimmer Biomet Holdings, Inc.
KSA 20.08.12

LIST OF TABLES

  • 1. GLOBAL SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 2. GLOBAL OCCULTA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL CLOSED NEURAL TUBE DEFECTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL MENINGOCELE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL MYELOMENINGOCELE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 7. GLOBAL SPINA BIFIDA SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL CESAREAN SECTION SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL SUPRAPUBIC CYSTOSTOMY SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL SPINAL SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL COLOSTOMY SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 12. GLOBAL OTHER SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 13. GLOBAL MEDICAL PROCEDURE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 14. GLOBAL URINARY CATHETERIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 15. GLOBAL URINARY DIVERSION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 16. GLOBAL ENEMA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 17. GLOBAL SPINA BIFIDA DEVICE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 18. GLOBAL SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 19. NORTH AMERICAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 20. NORTH AMERICAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 21. NORTH AMERICAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 22. EUROPEAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 23. EUROPEAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 24. EUROPEAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 25. ASIA-PACIFIC SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 26. ASIA-PACIFIC SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 27. ASIA-PACIFIC SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 28. REST OF THE WORLD SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 29. REST OF THE WORLD SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SPINA BIFIDA TREATMENT MARKET SHARE BY TYPE, 2018 VS 2025 (%)
  • 2. GLOBAL SPINA BIFIDA TREATMENT MARKET SHARE BY TREATMENT, 2018 VS 2025 (%)
  • 3. GLOBAL SPINA BIFIDA TREATMENT MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. ROE SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

Global Spina Bifida Treatment Market Size, Share & Trends Analysis Report, by Type (Occulta, Closed neural tube defects, Meningocele, and Myelomeningocele), by Treatment (Surgery {Cesarean section, Suprapubic cystostomy, Spinal Surgery, Colostomy, and Others}, Medical Procedure {Urinary catheterization, Urinary diversion, Enema}, and Devices) and Forecast Period 2019-2025

The global spina bifida treatment market is estimated to grow at a CAGR during the forecast period. Growing cases of spina bifida among the infants and medical advancement are driving the growth of the global spina bifida treatment market. Moreover, growing awareness, increasing government assistance, and rising funding and reimbursement are propelling the growth of the global spina bifida market.

The global spina bifida treatment market is segmented based on type and treatment. Based on the type, the market is segmented into occulta, closed neural tube defects, meningocele, and myelomeningocele. And based on the treatment, the market is segmented into surgery, medical procedures, and devices. Furthermore, based on the surgery, the market is further segmented into the cesarean section, suprapubic cystostomy, spinal surgery, colostomy, and others. Based on the medical procedure, the market is segmented into urinary catheterization, urinary diversion, enema.

Based on geography, the market is classified into four major regions, including North America, Europe, Asia-Pacific, and RoW. North America is expected to have a significant market share in the global spina bifida treatment market. Asia-Pacific region is the fastest-growing spina bifida treatment market owing to large numbers of the patient and increasing health awareness. Moreover, growing government-sponsored awareness, increasing government assistance, and rising funding and reimbursement are propelling the growth of the market.

The key players providing spina bifida treatment that includeMedtronic PLC, Boston Scientific Corp., Karl Storz SE & Co. KG, Johnson & Johnson Service, Inc., Zimmer Biomet Holdings, Inc., NuVasive, Inc, Smith & Nephew PLC, Stryker Corp., and Wellspect Healthcare (A Dentsply Sirona Company).The strategies adopted by the market players include joint venture and product launches, to increase their competitiveness across a global scale.

Research Methodology

The market study of the global spina bifida treatmentmarket is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

  • Reports of companies involved in the market
  • Authentic Public Databases
  • Whitepapers such as research papers and news blogs
  • Company websites and their product catalog

The report is intended for providers, suppliers, and distributors of fiberglass, for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and will serve as a source for 360-degree analysis of the market.

Market Segmentation-

  • Global Spina Bifida TreatmentMarket Research and Analysis by Type
  • Global Spina Bifida TreatmentMarket Research and Analysis by Treatment

The Report Covers:

  • Comprehensive research methodology of the global spina bifida treatmentmarket.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Insights about market determinants which are stimulating the global spina bifida treatment market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusions

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Medtronic PLC
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Boston Scientific Corp.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Karl Storz SE & Co. KG
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Johnson & Johnson Service, Inc.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Zimmer Biomet Holdings, Inc.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Spina Bifida Treatment Marketby Type
    • 5.1.1. Occulta
    • 5.1.2. Closed neural tube defects
    • 5.1.3. Meningocele
    • 5.1.4. Myelomeningocele
  • 5.2. Global Spina Bifida Treatment Marketby Treatment
    • 5.2.1. Surgery
      • 5.2.1.1. Cesarean section
      • 5.2.1.2. Suprapubic cystostomy
      • 5.2.1.3. Spinal Surgery
      • 5.2.1.4. Colostomy
      • 5.2.1.5. Others
    • 5.2.2. Medical Procedure
      • 5.2.2.1. Urinary Catheterization
      • 5.2.2.2. Urinary Diversion
      • 5.2.2.3. Enema
    • 5.2.3. Devices

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. B. Braun Melsungen AG
  • 7.2. Boston Scientific Corp.
  • 7.3. C.R. Bard, Inc. (Becton, Dickinson and Co.)
  • 7.4. Coloplast A/S
  • 7.5. ConvaTec Group PLC
  • 7.6. Cook Medical, Inc.
  • 7.7. Johnson & Johnson Service, Inc.
  • 7.8. Karl Storz SE & Co. KG
  • 7.9. Medtronic PLC
  • 7.10. NuVasive, Inc.
  • 7.11. Smith & Nephew PLC
  • 7.12. Stryker Corp.
  • 7.13. Teleflex, Inc.
  • 7.14. Wellspect Healthcare (A Dentsply Sirona Company)
  • 7.15. Zimmer Biomet Holdings, Inc.
Back to Top
전화 문의
F A Q